Drug details

Hydrea (hydroxyurea)

type of Antineoplastics, Antimetabolite

Hydrea (hydroxyurea) is an antineoplastic (anti-cancer) agent used to treat melanoma, resistant chronic myelocytic leukemia, and recurrent, metastatic, or inoperable carcinoma of the ovary and primary squamous cell (epidermoid) carcinomas of the head and neck. Hydrea is available in generic form.

This drug may have the following side effects:

• nausea,
• headache,
• dizziness,
• vomiting,
• diarrhea,
• constipation,
• upset stomach,
• rash,
• hair loss,
• weight gain.
• skin changes such as peeling or discoloration,
• flu-like symptoms,
• drowsiness, or

The following drugs are related to Hydrea, either as a replacement or used together:

• Adakveo (crizanlizumab-tmca injection)
• Agrylin (anagrelide)
• BESREMi (ropeginterferon alfa-2b-njft)
• Carboplatin (carboplatin injection)
• Copiktra (duvelisi capsules)
• Droxia (hydroxyurea capsules)
• Idhifa (enasidenib tablets)
• Endari (l-glutamine oral powder)
• Imlygic (talimogene laherparepvec suspension for intralesional injection)
• Oxbryta (voxelotor tablets)
• Rubraca Tablets (rucaparib)

The following supplements are related to Hydrea, and may be used together with the drug:

• Zinc (s.)
• Melatonin (s.)
• Adenosine (s.)
• Coriolus Mushroom (s.)